Clinical Trial Update: Investigation of Mass Balance of the Test Drug and Major Metabolites [Phase 1]

View source ↗

Summary

Phase 1 mass balance study investigating the test drug and its major metabolites in cancer (neoplasms) patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Bayer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED